632627-75-9

Upstream product

• 613-84-3 2-hydroxy-5-methylbenzaldehyde 
• 459-46-1 4-Fluorobenzyl bromide 

Downstream Products

• 632624-82-9 3-{2-[5-methyl-2-(4-fluorobenzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-5-(2-oxo-piperidin-1-yl)benzoic acid 
• 632624-83-0 3-{2-[5-methyl-2-(4-fluorobenzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-5-(1,1-dioxo-1/6-isothiazolidin-2-yl)benzoic acid 
• 632624-81-8 3-{2-[5-methyl-2-(4-fluorobenzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-5-(2-oxo-pyrrolidin-1-yl)benzoic acid 
• 632624-79-4 3-{2-[5-methyl-2-(4-fluorobenzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-5-trifluoromethylbenzoic acid 
• 632624-84-1 3-{2-[5-methyl-2-(4-fluorobenzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-6-acetylaminobenzoic acid 
• 632624-91-0 3-{2-[5-methyl-2-(4-fluorobenzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-5-acetylaminobenzoic acid 
• 632624-80-7 3-{2-[5-methyl-2-(4-fluoro-benzyloxy)-phenyl]-5-methyl-pyrrol-1-yl}-6-difluoromethoxy-benzoic acid 
• 632624-89-6 3-{2-[5-methyl-2-(4-fluorobenzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-6-chlorobenzoic acid 
• 632624-85-2 3-{2-[5-methyl-2-(4-fluorobenzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-5-aminobenzoic acid 
• 632624-87-4 3-{2-[5-methyl-2-(4-fluorobenzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-6-methylbenzoic acid 
• 632627-84-0 3-{2-[5-methyl-2-(4-fluorobenzyloxy)phenyl]-5-methyl-pyrrol-1-yl}-5-amino-6-methylbenzoic acid methyl ester 
• 632627-76-0 1-[5-methyl-2-(4-fluorobenzyloxy)phenyl]-pentane-1,4-dione 

Relevant academic research and scientific papers

PYRROLE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN MEDIATED DISEASES

Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, R1, R2a, R2b, Rx, R8, and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine, in particular their use in the treatment of prostaglandin mediated diseases such as pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.